The goal of the collaboration between $CBIS and Dana-Farber Cancer Institute, Inc is to develop and investigate the use of Cannabinoids in the treatment of a variety of cancers, and investigate the synergistic impact of cannabinoids when used together with standard and novel anti-cancer regimens.